financetom
Business
financetom
/
Business
/
Amgen to test its obesity drug in patients at risk of obesity-related diseases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amgen to test its obesity drug in patients at risk of obesity-related diseases
Sep 6, 2024 12:20 PM

Sept 4 (Reuters) - Amgen ( AMGN ) will test its obesity

drug candidate in patients at risk of obesity-related conditions

such as heart, liver and kidney diseases in its late-stage

trial, the company's CEO Robert Bradway said at a Morgan Stanley

healthcare conference on Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Xiaomi Asks Indian Watchdog to Recall Antitrust Report on Walmart India Unit Flipkart
Market Chatter: Xiaomi Asks Indian Watchdog to Recall Antitrust Report on Walmart India Unit Flipkart
Oct 3, 2024
08:29 AM EDT, 09/23/2024 (MT Newswires) -- Chinese smartphone maker Xiaomi has asked the Competition Commission of India to recall its antitrust report, which found Xiaomi and Walmart's ( WMT ) India unit Flipkart in breach of competition laws, Reuters reported Monday, citing people familiar with the matter. Any recall of the commission's report could cause a delay in its...
Bitfarms reaches agreement with Riot, Freedman appointed to board
Bitfarms reaches agreement with Riot, Freedman appointed to board
Oct 3, 2024
(Reuters) - Bitcoin miner Bitfarms ( BITF ) said on Monday it had entered into a settlement agreement with rival and top shareholder Riot Platforms ( RIOT ), under which Amy Freedman was appointed to its board. Freedman, a former investment banker who has helped companies with corporate governance matters, will replace Andrés Finkielsztain on the Bitfarms ( BITF )...
Carlyle-Backed StandardAero Seeks to Sell 46.5 Million Shares in Initial Public Offering
Carlyle-Backed StandardAero Seeks to Sell 46.5 Million Shares in Initial Public Offering
Oct 3, 2024
07:58 AM EDT, 09/23/2024 (MT Newswires) -- Carlyle Group ( CG )-backed (CG) StandardAero is seeking to sell 46.5 million shares of stock at an anticipated price of $20 to $23 per share in an initial public offering, the company said in a regulatory filing Monday. No date has yet been set for the offering. StandardAero expects to trade on...
UAE seeks closer AI, tech ties in Biden talks as China interest stirs US concern
UAE seeks closer AI, tech ties in Biden talks as China interest stirs US concern
Oct 3, 2024
* First time a UAE president visits White House * UAE ambitiously pursuing AI development * U.S. wary of UAE-China relationship By Alexander Cornwell DUBAI, Sept 23 (Reuters) - President Joe Biden will host the United Arab Emirates president on Monday for a visit set to include White House talks on the Gulf state's plans for artificial intelligence, an ambitious...
Copyright 2023-2026 - www.financetom.com All Rights Reserved